학술논문
Can Novel Myosin Inhibitors Defer Septal Reduction Therapy in HCM? At What Risk and at What Cost?
Document Type
Editorial & Opinion
Author
Rakowski H; Division of Cardiology, Peter Munk Cardiac Centre, Department of Medicine, Toronto General Hospital, Ontario, Canada (H.R., R.B.).; Bataiosu R; Division of Cardiology, Peter Munk Cardiac Centre, Department of Medicine, Toronto General Hospital, Ontario, Canada (H.R., R.B.).; Department of Cardiology, University Heart Center, University Hospital Zurich, Switzerland (E.B.).
Source
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4539 (Electronic) Linking ISSN: 00097322 NLM ISO Abbreviation: Circulation Subsets: MEDLINE
Subject
Language
English